News
Johnson & Johnson announced today first results from the Phase 3, randomized, double-blind, placebo-controlled AMPLITUDE study evaluating the combination of niraparib and abiraterone acetate plus ...
A phase I clinical trial has found that a novel combination of cannabidiol (CBD) and hydroxychloroquine (HCQ), known as IHL-675 A, is well tolerated and bioavailable in healthy volunteers, supporting ...
Deucrictibant data shows single-dose durability without symptom reoccurrence in the majority of HAE attacks treated First-ever bradykinin B2 receptor mechanism-on-mechanism prophylactic/on-demand data ...
Ahmedabad: Pharma major, Zydus Lifesciences Limited, has received tentative approval from the United States Food and Drug ...
Chinese factories tied to Xinjiang forced labour feed supply chains for practically every major carmaker – and tariffs won’t ...
In terms of value, PerfectAmino is on the premium end at around $1.50 per serving, but there are smart ways to save. You can ...
The best tech products announced this week include Bang & Olufsen's reimagined turntable and TCL's new flagship mini-LED TVs.
Alembic Pharma said that the drug is used for treating patients with chronic, accelerated, or blast phase Philadelphia ...
Best hyaluronic acid supplements for deep skin hydration and repair - Decoding the hydration supplements, with expert ...
It appears to be the generic version of a commonly prescribed drug used to alleviate symptoms experienced by 53 million ...
The development of oral dosage forms for clinical trials presents a unique set of challenges, particularly in early phases of ...
Viatris Inc. , a global healthcare company, today announced the launch in Canada of Gen-Clozapine orally disintegrating tablets (ODT) (12.5 mg, 25 mg, 50 mg, 100 mg and 200 mg), providing a new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results